Suppr超能文献

循环脂联素 2 水平可预测老年女性与骨折相关的住院治疗:一项前瞻性队列研究。

Circulating Lipocalin 2 Levels Predict Fracture-Related Hospitalizations in Elderly Women: A Prospective Cohort Study.

机构信息

University of Western Australia School of Medicine and Pharmacology, Sir Charles Gairdner Hospital Unit, Perth, Australia.

Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.

出版信息

J Bone Miner Res. 2015 Nov;30(11):2078-85. doi: 10.1002/jbmr.2546. Epub 2015 May 21.

Abstract

Lipocalin 2 (LCN2) or neutrophil gelatinase-associated lipocalin (NGAL) is expressed in a wide range of cells and pathological states. Mounting evidence suggests lipocalin 2 may be an important regulator of bone homeostasis. Recently it has been suggested LCN2 is a novel mechanoresponsive gene central to the pathological response to low mechanical force. We undertook a prospective study of 1009 elderly women over 70 years of age to study the association between circulating LCN2 and potential associated variables, including estimated glomerular filtration rate, physical activity, and baseline measures of hip bone density and heel bone quality. Osteoporotic fractures requiring hospitalizations were identified from the Western Australian Data Linkage System. Over 14.5 years, 272 (27%) of women sustained an osteoporotic fracture-related hospitalization; of these, 101 were hip fractures. Circulating LCN2 levels were correlated with body mass index and estimated glomerular filtration rate (r = 0.249, p < 0.001 and r = -0.481, p < 0.001, respectively) that modified the association with hip and heel bone measures. Per standard deviation increase in LCN2, there was a 30% multivariable-adjusted increase in the risk of any osteoporotic fracture (hazard ratio [HR] = 1.30, 95% confidence interval [CI] 1.13-1.50, p < 0.001). In participants with elevated LCN2 levels above the median (76.6 ng/mL), there was an 80% to 81% increase in the risk of any osteoporotic or hip fracture (HR = 1.81, 95% CI 1.38-2.36, p < 0.001 and HR = 1.80, 95% CI 1.16-2.78, p = 0.008, respectively). These associations remained significant after adjustment for total hip bone mineral density (p < 0.05). In conclusion, we have demonstrated that circulating LCN2 levels predict future risk of osteoporotic fractures requiring hospitalization. Measurement of LCN2 levels may improve fracture prediction in addition to current fracture risk factors in the elderly, particularly in those with impaired renal function.

摘要

脂质运载蛋白 2(LCN2)或中性粒细胞明胶酶相关脂质运载蛋白(NGAL)在广泛的细胞和病理状态下表达。越来越多的证据表明,脂质运载蛋白 2 可能是骨稳态的重要调节剂。最近,有人提出 LCN2 是一种新型的机械反应基因,是对低机械力的病理反应的核心。我们对 1009 名 70 岁以上的老年女性进行了前瞻性研究,以研究循环 LCN2 与潜在相关变量之间的关系,包括估计肾小球滤过率、身体活动以及髋骨密度和脚跟骨质量的基线测量值。通过西澳大利亚数据链接系统确定需要住院治疗的骨质疏松性骨折。在超过 14.5 年的时间里,272 名(27%)女性发生了与骨质疏松性骨折相关的住院治疗;其中 101 名是髋部骨折。循环 LCN2 水平与体重指数和估计肾小球滤过率相关(r=0.249,p<0.001 和 r=-0.481,p<0.001),分别改变了与髋部和脚跟骨测量值的关联。LCN2 每增加一个标准差,多变量调整后的任何骨质疏松性骨折风险增加 30%(风险比[HR]=1.30,95%置信区间[CI]1.13-1.50,p<0.001)。在 LCN2 水平高于中位数(76.6ng/mL)的参与者中,任何骨质疏松性或髋部骨折的风险增加了 80%至 81%(HR=1.81,95%CI 1.38-2.36,p<0.001 和 HR=1.80,95%CI 1.16-2.78,p=0.008)。这些关联在调整全髋骨矿物质密度后仍然显著(p<0.05)。总之,我们已经证明,循环 LCN2 水平可以预测未来需要住院治疗的骨质疏松性骨折的风险。在老年人中,除了目前的骨折危险因素外,测量 LCN2 水平可能会改善骨折预测,特别是在肾功能受损的患者中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验